Rouvax Measles vaccine

Pajjiż: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Measles vaccine 1000 TCID50

Disponibbli minn:

Seqirus (NZ) Ltd

INN (Isem Internazzjonali):

Measles vaccine 1000 TCID50

Dożaġġ:

1000 TCID50

Għamla farmaċewtika:

Suspension for injection

Kompożizzjoni:

Active: Measles vaccine 1000 TCID50 Excipient: Alanine Arginine hydrochloride Asparagine Aspartic acid Cysteine Cysteine hydrochloride monohydrate Dextran 70 Glutamic acid Glycine Histidine Isoleucine Leucine Lysine hydrochloride Methionine Neomycin sulfate Phenolsulfonphthalein Phenylalanine Proline Serine Sorbitol Threonine Tryptophan Tyrosine Urea Valine Water for injection

Unitajiet fil-pakkett:

Ampoule, glass, 1 x 0.5 mL, 0.5 mL

Klassi:

Prescription

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Sanofi Pasteur SA

Sommarju tal-prodott:

Package - Contents - Shelf Life: Ampoule, glass, 1 x 0.5 mL - 0.5 mL - 24 months from date of manufacture stored at or below 25°C - Combination pack, 1 x ( powder + diluent ) - 1 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 10 x ( powder + diluent ) - 10 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light - Vial, glass, single dose, 1 x 1,000TCID50 - 1 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Data ta 'l-awtorizzazzjoni:

1982-11-04